Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows No longer looking for participants and lists 226 study locations (down from 264). It also updates the primary completion date to 2026-08-10 and the study completion date to 2027-09-08, with a protocol revision noted as Revision: v3.6.6.SummaryDifference6%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer now displays Revision: v3.6.5, up from Revision: v3.6.4, indicating a deployment update.SummaryDifference0.0%

- Check37 days agoChange DetectedThis change updates the revision from v3.6.3 to v3.6.4, indicating a small update to the page's documentation or release notes. It does not alter the page's primary information or user-facing features.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page text remains unchanged. No new content or deletions were detected in the study record.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s revision tag was updated from v3.6.1 to v3.6.3, indicating a minor update to the page’s metadata rather than a substantive change to study details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now lists Revision: v3.6.1, replacing Revision: v3.6.0.SummaryDifference0.0%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.